Comparing QuidelOrtho (QDEL) and The Competition

QuidelOrtho (NASDAQ:QDEL) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare QuidelOrtho to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, risk, earnings, profitability and dividends.

Insider and Institutional Ownership

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 40.6% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 1.1% of QuidelOrtho shares are held by insiders. Comparatively, 15.0% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares QuidelOrtho and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
QuidelOrtho	$2.73 billion	-$1.13 billion	-2.13
QuidelOrtho Competitors	$1.88 billion	$139.14 million	12.53

QuidelOrtho has higher revenue, but lower earnings than its peers. QuidelOrtho is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

QuidelOrtho has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, QuidelOrtho’s peers have a beta of 2.57, suggesting that their average share price is 157% more volatile than the S&P 500.

Profitability

This table compares QuidelOrtho and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-14.24%	3.22%	1.03%
QuidelOrtho Competitors	-276.78%	-149.08%	-21.73%

Analyst Recommendations

This is a summary of current ratings and price targets for QuidelOrtho and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	2	4	0	0	1.67
QuidelOrtho Competitors	4285	10564	18343	830	2.46

QuidelOrtho presently has a consensus price target of $13.62, indicating a potential upside of 18.06%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.47%. Given QuidelOrtho’s peers stronger consensus rating and higher probable upside, analysts plainly believe QuidelOrtho has less favorable growth aspects than its peers.

Summary

QuidelOrtho peers beat QuidelOrtho on 8 of the 13 factors compared.

About QuidelOrtho

QuidelOrtho Corporation (NASDAQ:QDEL) is a global in vitro diagnostics company formed through the combination of Quidel Corporation and Ortho Clinical Diagnostics, a transaction completed in 2022. The company develops, manufactures and markets diagnostic technologies used to detect disease, guide treatment decisions and support blood-transfusion safety. Its portfolio includes rapid immunoassays, molecular testing systems, clinical chemistry and immunohematology products, as well as laboratory automation solutions.